Single-inhaler triple therapy for COPD: When one is better than more
21 Sep 2020
byAudrey Abella
A single-inhaler triple therapy containing FF/UMEC/VI* may be a good option for COPD** patients who remain symptomatic despite dual bronchodilation with an ICS/LABA or a LAMA/LABA*** and at risk for exacerbations, according to data presented at ERS 2020.
Single-inhaler triple therapy for COPD: When one is better than more
21 Sep 2020
